SCHEMBL30746542

SCHEMBL30746542

CC(=O)Nc1nccc(Cc2cncc(Nc3ccc(Br)cc3F)c2C)c1F

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ EGFR P00533 10/20 0.36
▸ KDR P35968 10/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PIK3C3 Q8NEB9 1/20 0.35
▸ GRK2 P25098 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CTDSP1 Q9GZU7 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ FPR2 P25090 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985226 1.00 HDAC3 (0.39) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL30746618 0.92 HDAC3 (0.39) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL26985145 0.92 HDAC3 (0.39) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL30746501 0.91 HDAC1 (0.38) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL26985151 0.91 HDAC1 (0.38) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL30746491 0.85 SLC22A12 (0.36) HDAC3HDAC1HDAC6GAAEGFR
SCHEMBL26985172 0.85 SLC22A12 (0.36) HDAC3HDAC1HDAC6GAAEGFR
SCHEMBL30746420 0.84 RAF1 (0.42) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL26985095 0.84 RAF1 (0.42) HDAC3HDAC1HDAC6GAAL3MBTL1
SCHEMBL30746672 0.82 MAPK1 (0.35) GAAL3MBTL1EGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback